Skip to main content
. 2019 Sep 30;37(3):166–175. doi: 10.3857/roj.2019.00220

Fig. 2.

Fig. 2.

Locoregional progression-free survival (LRPFS) according to to NLR and PLR: (A) post-CCRT NLR, (B) NLR change (post-CCRT NLR / pre-CCRT NLR), and (C) post-CCRT PLR. NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; CCRT, concurrent chemoradiotherapy.